UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium

Chemico-biological interactions, 2012-10, Vol.200 (1), p.45-64

2012

Volltextzugriff (PDF)

Physiologically based pharmacokinetic model for humans orally exposed to chromium

Chemico-biological interactions, 2013-06, Vol.204 (1), p.13-27

2013

Volltextzugriff (PDF)

Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion

Food and chemical toxicology, 2009-04, Vol.47 (4), p.760-768

2009

Volltextzugriff (PDF)

An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene

Chemico-biological interactions, 2022-10, Vol.366, p.110077, Article 110077

2022

Volltextzugriff (PDF)

Derivation of endogenous equivalent values to support risk assessment and risk management decisions for an endogenous carcinogen: Ethylene oxide

Regulatory toxicology and pharmacology, 2017-12, Vol.91, p.165-172

2017

Volltextzugriff (PDF)

Corrigendum to “An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene” [Chem. Biol. Interact. 366 (2022) 1–10]

Chemico-biological interactions, 2023-11, Vol.385, p.110736-110736, Article 110736

2023

Volltextzugriff (PDF)

Science peer review for the 21st century: Assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process bias

Regulatory toxicology and pharmacology, 2019-04, Vol.103, p.73-85

2019

Volltextzugriff (PDF)

Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts

Regulatory toxicology and pharmacology, 2022-10, Vol.134, p.105226-105226, Article 105226

2022

Volltextzugriff (PDF)

Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadiene

Regulatory toxicology and pharmacology, 2022-10, Vol.134, p.105239-105239, Article 105239

2022

Volltextzugriff (PDF)

Derivation of no significant risk levels for three lower acrylates: Conclusions and recommendations from an expert panel

Regulatory toxicology and pharmacology, 2024-03, Vol.148, p.105567-105567, Article 105567

2024

Volltextzugriff (PDF)

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

Regulatory toxicology and pharmacology, 2003-12, Vol.38 (3), p.345-367

2003

Volltextzugriff (PDF)

Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations

Toxicology and applied pharmacology, 2017-06, Vol.325, p.9-17

2017

Volltextzugriff (PDF)

Cancer weight of evidence for three lower acrylates: Conclusions and recommendations from an expert panel

Regulatory toxicology and pharmacology, 2023-09, Vol.143, p.105469-105469, Article 105469

2023

Volltextzugriff (PDF)

A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review

Regulatory toxicology and pharmacology, 2023-09, Vol.143, p.105444-105444, Article 105444

2023

Volltextzugriff (PDF)

An evaluation of reproductive toxicity studies and data interpretation of N-methylpyrrolidone for risk assessment: An expert panel review

Regulatory toxicology and pharmacology, 2023-02, Vol.138, p.105337, Article 105337

2023

Volltextzugriff (PDF)

Biomonitoring Equivalents for cyanide

Regulatory toxicology and pharmacology, 2018-08, Vol.97, p.71-81

2018

Volltextzugriff (PDF)

Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine

Regulatory toxicology and pharmacology, 2016-04, Vol.76, p.137-151

2016

Volltextzugriff (PDF)

Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone

Regulatory toxicology and pharmacology, 2016-04, Vol.76, p.102-112

2016

Volltextzugriff (PDF)

Quantitative human health risk assessment for 1,3-butadiene based upon ovarian effects in rodents

Regulatory toxicology and pharmacology, 2012-03, Vol.62 (2), p.371-384

2012

Volltextzugriff (PDF)

Corrigendum to “Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium” [Chem Biol Interact 2012;200:45–64]

Chemico-biological interactions, 2013-08, Vol.204 (3), p.201-206

2013

Volltextzugriff (PDF)

Erratum to: “Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion” [Food and Chemical Toxicology 47 (2009) 760–768]

Food and chemical toxicology, 2009-11, Vol.47 (11), p.2875-2875

2009

Volltextzugriff (PDF)

Response to, “ Reaction on Gargas et al.: Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion”, by Hogervorst et al

Food and chemical toxicology, 2009-11, Vol.47 (11), p.2873-2874

2009

Volltextzugriff (PDF)

Derivation of Noncancer Reference Values for Acrylonitrile

Risk analysis, 2008-10, Vol.28 (5), p.1375-1394

2008

Volltextzugriff (PDF)

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

Regulatory toxicology and pharmacology, 2005-10, Vol.43 (1), p.85-103

2005

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium

Physiologically based pharmacokinetic model for humans orally exposed to chromium

Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion

An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene

Derivation of endogenous equivalent values to support risk assessment and risk management decisions for an endogenous carcinogen: Ethylene oxide

Corrigendum to “An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene” [Chem. Biol. Interact. 366 (2022) 1–10]

Science peer review for the 21st century: Assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process bias

Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts

Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadiene

Derivation of no significant risk levels for three lower acrylates: Conclusions and recommendations from an expert panel

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations

Cancer weight of evidence for three lower acrylates: Conclusions and recommendations from an expert panel

A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review

An evaluation of reproductive toxicity studies and data interpretation of N-methylpyrrolidone for risk assessment: An expert panel review

Biomonitoring Equivalents for cyanide

Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine

Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone

Quantitative human health risk assessment for 1,3-butadiene based upon ovarian effects in rodents

Corrigendum to “Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium” [Chem Biol Interact 2012;200:45–64]

Erratum to: “Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion” [Food and Chemical Toxicology 47 (2009) 760–768]

Response to, “ Reaction on Gargas et al.: Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion”, by Hogervorst et al

Derivation of Noncancer Reference Values for Acrylonitrile

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

Suchergebnisse filtern